<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1060"/><api:result><api:object category="publication" id="1060" last-affected-when="2024-04-15T00:49:03.853+01:00" last-modified-when="2024-04-15T00:49:03.853+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1060" created-when="2010-05-17T13:47:30.637+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2001-12-25</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1492046" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1046/j.1365-2990.2000.026002133.x" last-modified-when="2023-11-04T02:44:38.597+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:p&gt;The recruitment of leucocytes to sites of inflammation is an important feature of multiple sclerosis (MS) pathology. Chemokines are involved in the activation and specific directional migration of monocytes and T‐lymphocytes to sites of inflammation. Using immunocytochemistry, the expression of the α‐chemokines, interferon (IFN)‐γ‐inducible protein‐10 (IP‐10) and monokine induced by IFN‐γ (Mig), and their receptor CXCR3 have been examined in &lt;jats:italic&gt;post‐mortem&lt;/jats:italic&gt; central nervous system (CNS) tissue from MS cases at different stages of lesion development. In actively demyelinating lesions both IP‐10 and Mig protein were predominantly expressed by macrophages within the plaque and by reactive astrocytes in the surrounding parenchyma. CXCR3 was expressed by T cells and by astrocytes within the plaque. Interferon‐γ may stimulate glial cells to express IP‐10 and Mig, which continue the local inflammatory response by selectively recruiting activated T‐lymphocytes into the CNS.&lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="288" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/288"/></api:links><api:last-name>Simpson</api:last-name><api:initials>JE</api:initials><api:first-names>JE</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Newcombe</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Cuzner</api:last-name><api:initials>ML</api:initials><api:first-names>ML</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Woodroofe</api:last-name><api:initials>MN</api:initials><api:first-names>MN</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>N</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2990.2000.026002133.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2990.2000.026002133.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2990.2000.026002133.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2990</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0305-1846</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Neuropathology and Applied Neurobiology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>25</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>133</api:begin-page><api:end-page>142</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1046/j.1365-2990.2000.026002133.x</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of the interferon‐γ‐inducible chemokines IP‐10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>26</api:text></api:field></api:native></api:record><api:record format="native" id="95909" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034055609" last-modified-when="2024-03-13T14:40:09.77+00:00"><api:citation-count>190</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The recruitment of leucocytes to sites of inflammation is an important feature of multiple sclerosis (MS) pathology. Chemokines are involved in the activation and specific directional migration of monocytes and T-lymphocptes to sites of inflammation. Using immunocytochemistry, the expression of the α-chemokines, interferon (IFN)-γ-inducible protein-10 (TP-10) and monokine induced by IFN-γ (Mig), and their receptor CXCR3 have been examined in post-mortem central nervous system (CNS) tissue from MS cases at different stages of lesion development. In actively demyelinating lesions both IP-10 and Mig protein were predominantly expressed by macrophages within the plaque and by reactive astrocytes in the surrounding parenchyma. CXCR3 was expressed by T cells and by astrocytes within the plaque. Interferon-γ may stimulate glial cells to express IP-10 and Mig, which continue the local inflammatory response by selectively recruiting activated T-lymphocytes into the CNS.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="288" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/288"/></api:links><api:last-name>Simpson</api:last-name><api:initials>JE</api:initials><api:first-names>JE</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Sheffield Hallam University</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">18937538100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Newcombe</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">UCL Queen Square Institute of Neurology</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">8541726600</api:identifier></api:identifiers></api:person><api:person><api:last-name>Cuzner</api:last-name><api:initials>ML</api:initials><api:first-names>ML</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">UCL Queen Square Institute of Neurology</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006460759</api:identifier></api:identifiers></api:person><api:person><api:last-name>Woodroofe</api:last-name><api:initials>MN</api:initials><api:first-names>MN</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Sheffield Hallam University</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006246898</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2990.2000.026002133.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2990.2000.026002133.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2990.2000.026002133.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10840276</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0305-1846</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Neuropathology and Applied Neurobiology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>133</api:begin-page><api:end-page>142</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of the interferon-γ-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>26</api:text></api:field></api:native></api:record><api:record format="native" id="1060" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10840276" last-modified-when="2020-04-29T06:10:43.273+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The recruitment of leucocytes to sites of inflammation is an important feature of multiple sclerosis (MS) pathology. Chemokines are involved in the activation and specific directional migration of monocytes and T-lymphocytes to sites of inflammation. Using immunocytochemistry, the expression of the alpha-chemokines, interferon (IFN)-gamma-inducible protein-10 (IP-10) and monokine induced by IFN-gamma (Mig), and their receptor CXCR3 have been examined in post-mortem central nervous system (CNS) tissue from MS cases at different stages of lesion development. In actively demyelinating lesions both IP-10 and Mig protein were predominantly expressed by macrophages within the plaque and by reactive astrocytes in the surrounding parenchyma. CXCR3 was expressed by T cells and by astrocytes within the plaque. Interferon-gamma may stimulate glial cells to express IP-10 and Mig, which continue the local inflammatory response by selectively recruiting activated T-lymphocytes into the CNS.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="288" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/288"/></api:links><api:last-name>Simpson</api:last-name><api:initials>JE</api:initials><api:first-names>JE</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Biomedical Sciences, Sheffield Hallam University, Sheffield, South Yorkshire and Multiple Sclerosis Laboratory, Institute of Neurology, London, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Newcombe</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Cuzner</api:last-name><api:initials>ML</api:initials><api:first-names>ML</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Woodroofe</api:last-name><api:initials>MN</api:initials><api:first-names>MN</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>N</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10840276</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2990.2000.026002133.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2990.2000.026002133.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2990.2000.026002133.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0305-1846</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Neuropathol Appl Neurobiol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Antibody Specificity</api:keyword><api:keyword scheme="mesh">Central Nervous System</api:keyword><api:keyword scheme="mesh">Chemokine CXCL10</api:keyword><api:keyword scheme="mesh">Chemokine CXCL9</api:keyword><api:keyword scheme="mesh">Chemokines, CXC</api:keyword><api:keyword scheme="mesh">Demyelinating Diseases</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Gene Expression</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">In Situ Hybridization</api:keyword><api:keyword scheme="mesh">Intercellular Signaling Peptides and Proteins</api:keyword><api:keyword scheme="mesh">Interferon-gamma</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Multiple Sclerosis</api:keyword><api:keyword scheme="mesh">RNA, Messenger</api:keyword><api:keyword scheme="mesh">Receptors, CXCR3</api:keyword><api:keyword scheme="mesh">Receptors, Chemokine</api:keyword><api:keyword scheme="mesh">T-Lymphocytes</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>133</api:begin-page><api:end-page>142</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>nan231</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>28</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>26</api:text></api:field></api:native></api:record><api:record format="native" id="882227" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10840276" last-modified-when="2024-03-26T19:42:38.987+00:00"><api:citation-count>139</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The recruitment of leucocytes to sites of inflammation is an important feature of multiple sclerosis (MS) pathology. Chemokines are involved in the activation and specific directional migration of monocytes and T-lymphocytes to sites of inflammation. Using immunocytochemistry, the expression of the alpha-chemokines, interferon (IFN)-gamma-inducible protein-10 (IP-10) and monokine induced by IFN-gamma (Mig), and their receptor CXCR3 have been examined in post-mortem central nervous system (CNS) tissue from MS cases at different stages of lesion development. In actively demyelinating lesions both IP-10 and Mig protein were predominantly expressed by macrophages within the plaque and by reactive astrocytes in the surrounding parenchyma. CXCR3 was expressed by T cells and by astrocytes within the plaque. Interferon-gamma may stimulate glial cells to express IP-10 and Mig, which continue the local inflammatory response by selectively recruiting activated T-lymphocytes into the CNS.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Biomedical Sciences, Sheffield Hallam University, Sheffield, South Yorkshire and Multiple Sclerosis Laboratory, Institute of Neurology, London, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="288" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/288"/></api:links><api:last-name>Simpson</api:last-name><api:initials>JE</api:initials><api:first-names>JE</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Newcombe</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0001-9609-7975</api:identifier></api:identifiers></api:person><api:person><api:last-name>Cuzner</api:last-name><api:initials>ML</api:initials><api:first-names>ML</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Woodroofe</api:last-name><api:initials>MN</api:initials><api:first-names>MN</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>N</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-8818-331X</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2990.2000.026002133.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2990.2000.026002133.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2990.2000.026002133.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2990</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10840276</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0305-1846</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Neuropathology and applied neurobiology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Central Nervous System</api:keyword><api:keyword scheme="mesh">T-Lymphocytes</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Sclerosis</api:keyword><api:keyword scheme="mesh">Demyelinating Diseases</api:keyword><api:keyword scheme="mesh">Intercellular Signaling Peptides and Proteins</api:keyword><api:keyword scheme="mesh">Receptors, Chemokine</api:keyword><api:keyword scheme="mesh">RNA, Messenger</api:keyword><api:keyword scheme="mesh">Chemokines, CXC</api:keyword><api:keyword scheme="mesh">In Situ Hybridization</api:keyword><api:keyword scheme="mesh">Antibody Specificity</api:keyword><api:keyword scheme="mesh">Gene Expression</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Chemokine CXCL10</api:keyword><api:keyword scheme="mesh">Receptors, CXCR3</api:keyword><api:keyword scheme="mesh">Chemokine CXCL9</api:keyword><api:keyword scheme="mesh">Interferon-gamma</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>133</api:begin-page><api:end-page>142</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>7</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>26</api:text></api:field></api:native></api:record><api:record format="native" id="2503161" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1056737563" last-modified-when="2024-04-15T00:49:03.86+01:00"><api:citation-count>183</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>6</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="288" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/288"/></api:links><api:last-name>Simpson</api:last-name><api:initials>JE</api:initials><api:first-names>JE</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Sheffield Hallam University</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0733347755.49</api:identifier></api:identifiers></api:person><api:person><api:last-name>Newcombe</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0646336662.25</api:identifier></api:identifiers></api:person><api:person><api:last-name>Cuzner</api:last-name><api:initials>ML</api:initials><api:first-names>ML</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01107232457.38</api:identifier></api:identifiers></api:person><api:person><api:last-name>Woodroofe</api:last-name><api:initials>MN</api:initials><api:first-names>MN</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Sheffield Hallam University</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01367705265.61</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2990.2000.026002133.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2990.2000.026002133.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2990.2000.026002133.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10840276</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>17.27</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0305-1846</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Neuropathology and Applied Neurobiology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3204 Immunology</api:keyword><api:keyword scheme="rcdc">Brain Disorders</api:keyword><api:keyword scheme="rcdc">Autoimmune Disease</api:keyword><api:keyword scheme="rcdc">Multiple Sclerosis</api:keyword><api:keyword scheme="rcdc">Neurosciences</api:keyword><api:keyword scheme="rcdc">Neurodegenerative</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-hc">Inflammatory and immune system</api:keyword><api:keyword scheme="hrcs-hc">Neurological</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Antibody Specificity</api:keyword><api:keyword scheme="mesh">Central Nervous System</api:keyword><api:keyword scheme="mesh">Chemokine CXCL10</api:keyword><api:keyword scheme="mesh">Chemokine CXCL9</api:keyword><api:keyword scheme="mesh">Chemokines, CXC</api:keyword><api:keyword scheme="mesh">Demyelinating Diseases</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Gene Expression</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">In Situ Hybridization</api:keyword><api:keyword scheme="mesh">Intercellular Signaling Peptides and Proteins</api:keyword><api:keyword scheme="mesh">Interferon-gamma</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Multiple Sclerosis</api:keyword><api:keyword scheme="mesh">RNA, Messenger</api:keyword><api:keyword scheme="mesh">Receptors, CXCR3</api:keyword><api:keyword scheme="mesh">Receptors, Chemokine</api:keyword><api:keyword scheme="mesh">T-Lymphocytes</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>25</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>133</api:begin-page><api:end-page>142</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>3.43</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of the interferon‐γ‐inducible chemokines IP‐10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>26</api:text></api:field></api:native></api:record><api:record format="native" id="241672" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000087209300004" last-modified-when="2024-03-14T05:58:13.583+00:00"><api:citation-count>177</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="288" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/288"/></api:links><api:last-name>Simpson</api:last-name><api:initials>JE</api:initials><api:first-names>JE</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Newcombe</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Cuzner</api:last-name><api:initials>ML</api:initials><api:first-names>ML</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Woodroofe</api:last-name><api:initials>MN</api:initials><api:first-names>MN</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>N</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000087209300004&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2990.2000.026002133.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2990.2000.026002133.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2990.2000.026002133.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">317CV</api:identifier><api:identifier scheme="pubmed">10840276</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0305-1846</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>chemokines</api:keyword><api:keyword>IP-10</api:keyword><api:keyword>Mig</api:keyword><api:keyword>IFN-gamma</api:keyword><api:keyword>CXCR3</api:keyword><api:keyword>inflammation</api:keyword><api:keyword>multiple sclerosis</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>133</api:begin-page><api:end-page>142</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of the interferon-γ-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>26</api:text></api:field></api:native></api:record><api:record format="native" id="24756" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000087209300004" last-modified-when="2014-07-25T11:07:13.567+01:00"><api:citation-count>116</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="288" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/288"/></api:links><api:last-name>Simpson</api:last-name><api:initials>JE</api:initials><api:first-names>JE</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Newcombe</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Cuzner</api:last-name><api:initials>ML</api:initials><api:first-names>ML</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Woodroofe</api:last-name><api:initials>MN</api:initials><api:first-names>MN</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>N</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0305-1846</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>NEUROPATH APPL NEURO</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>chemokines</api:keyword><api:keyword>IP-10</api:keyword><api:keyword>Mig</api:keyword><api:keyword>IFN-gamma</api:keyword><api:keyword>CXCR3</api:keyword><api:keyword>inflammation</api:keyword><api:keyword>multiple sclerosis</api:keyword><api:keyword>IN-SITU HYBRIDIZATION</api:keyword><api:keyword>EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS</api:keyword><api:keyword>EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS</api:keyword><api:keyword>MONOCYTE CHEMOATTRACTANT PROTEIN-1</api:keyword><api:keyword>MYELIN BASIC-PROTEIN</api:keyword><api:keyword>ADULT-RAT BRAIN</api:keyword><api:keyword>FUNCTIONAL EXPRESSION</api:keyword><api:keyword>MOLECULAR-CLONING</api:keyword><api:keyword>CYTOKINE FAMILY</api:keyword><api:keyword>T-LYMPHOCYTES</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>133</api:begin-page><api:end-page>142</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>26</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antibody Specificity</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Central Nervous System</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Chemokine CXCL10</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Chemokine CXCL9</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Chemokines, CXC</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Demyelinating Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Gene Expression</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">In Situ Hybridization</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Intercellular Signaling Peptides and Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interferon-gamma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Multiple Sclerosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">RNA, Messenger</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Receptors, CXCR3</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Receptors, Chemokine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">T-Lymphocytes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Central Nervous System</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">T-Lymphocytes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Multiple Sclerosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Demyelinating Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Intercellular Signaling Peptides and Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Receptors, Chemokine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">RNA, Messenger</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Chemokines, CXC</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">In Situ Hybridization</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antibody Specificity</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Gene Expression</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Chemokine CXCL10</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Receptors, CXCR3</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Chemokine CXCL9</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interferon-gamma</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3204 Immunology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Brain Disorders</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Autoimmune Disease</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Multiple Sclerosis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Neurosciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Neurodegenerative</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Inflammatory and immune system</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Neurological</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antibody Specificity</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Central Nervous System</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Chemokine CXCL10</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Chemokine CXCL9</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Chemokines, CXC</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Demyelinating Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Gene Expression</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">In Situ Hybridization</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Intercellular Signaling Peptides and Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interferon-gamma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Multiple Sclerosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">RNA, Messenger</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Receptors, CXCR3</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Receptors, Chemokine</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">T-Lymphocytes</api:keyword><api:keyword origin="record-data" source="wos-lite">chemokines</api:keyword><api:keyword origin="record-data" source="wos-lite">IP-10</api:keyword><api:keyword origin="record-data" source="wos-lite">Mig</api:keyword><api:keyword origin="record-data" source="wos-lite">IFN-gamma</api:keyword><api:keyword origin="record-data" source="wos-lite">CXCR3</api:keyword><api:keyword origin="record-data" source="wos-lite">inflammation</api:keyword><api:keyword origin="record-data" source="wos-lite">multiple sclerosis</api:keyword><api:keyword origin="record-data" source="wos">chemokines</api:keyword><api:keyword origin="record-data" source="wos">IP-10</api:keyword><api:keyword origin="record-data" source="wos">Mig</api:keyword><api:keyword origin="record-data" source="wos">IFN-gamma</api:keyword><api:keyword origin="record-data" source="wos">CXCR3</api:keyword><api:keyword origin="record-data" source="wos">inflammation</api:keyword><api:keyword origin="record-data" source="wos">multiple sclerosis</api:keyword><api:keyword origin="record-data" source="wos">IN-SITU HYBRIDIZATION</api:keyword><api:keyword origin="record-data" source="wos">EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS</api:keyword><api:keyword origin="record-data" source="wos">EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS</api:keyword><api:keyword origin="record-data" source="wos">MONOCYTE CHEMOATTRACTANT PROTEIN-1</api:keyword><api:keyword origin="record-data" source="wos">MYELIN BASIC-PROTEIN</api:keyword><api:keyword origin="record-data" source="wos">ADULT-RAT BRAIN</api:keyword><api:keyword origin="record-data" source="wos">FUNCTIONAL EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">MOLECULAR-CLONING</api:keyword><api:keyword origin="record-data" source="wos">CYTOKINE FAMILY</api:keyword><api:keyword origin="record-data" source="wos">T-LYMPHOCYTES</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1109 Neurosciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1702 Cognitive Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Neurology &amp; Neurosurgery</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3209 Neurosciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0305-1846" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974296" title="Neuropathology and Applied Neurobiology"><api:records><api:record source-name="summary"><api:title>Neuropathology and Applied Neurobiology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1060/relationships"/></api:object></api:result></api:response>